Koyfin Home > Directory > Health Care > Aldeyra Therapeu > Long-Term Debt

Aldeyra Therapeu Long-Term Debt Chart (ALDX)

Aldeyra Therapeu annual/quarterly Long-Term Debt from 2012 to 2020.
  • Aldeyra Therapeu Long-Term Debt for the quarter ending June 06, 2020 was $14m a -3.37% decrease of 0m year over year
  • Aldeyra Therapeu Long-Term Debt for the last 12 months ending June 06, 2020 was $14m a -3.37% decrease of 0m year over year
  • Aldeyra Therapeu Annual Long-Term Debt for 2019 was $15m a 91.60% increase of 13m from 2018
  • Aldeyra Therapeu Annual Long-Term Debt for 2017 was $1m a -1.51% decrease of 0m from 2016
  • Aldeyra Therapeu Annual Long-Term Debt for 2016 was $1m a 2.21% increase of 0m from 2015
Other Cash Flow Metrics:
  • Aldeyra Therapeu Cash Flow from Operations for the quarter ending September 09, 2018 was $-8m a 34.73% decrease of -3m year over year
  • Aldeyra Therapeu Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $2m a 206.88% increase of 5m year over year
View Chart On Koyfin

Quarterly ALDX Long-Term Debt Data

06/2020$14m
03/2020$15m
12/2019$15m
09/2019$14m
09/2018$1m
06/2018$1m
03/2018$1m
12/2017$1m
09/2017$1m
06/2017$1m

Annual ALDX Long-Term Debt Data

2019$15m
2017$1m
2016$1m
2015$1m
2014$1m
2013$1m
2012$0m